Search company, investor...

NanoPharmaceuticals

Stage

Unattributed - III | Alive

Total Raised

$5.95M

Last Raised

$1.33M | 5 yrs ago

About NanoPharmaceuticals

NanoPharmaceuticals is a stealth pharmaceutical company.

Headquarters Location

1 Discovery Drive

Rensselaer, New York, 12144,

United States

917-612-1105

Missing: NanoPharmaceuticals's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: NanoPharmaceuticals's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

NanoPharmaceuticals Patents

NanoPharmaceuticals has filed 19 patents.

The 3 most popular patent topics include:

  • Clusters of differentiation
  • Transcription factors
  • Integrins
patents chart

Application Date

Grant Date

Title

Related Topics

Status

6/7/2021

6/7/2022

Clusters of differentiation, Transcription factors, Ion channels, Integrins, Amines

Grant

Application Date

6/7/2021

Grant Date

6/7/2022

Title

Related Topics

Clusters of differentiation, Transcription factors, Ion channels, Integrins, Amines

Status

Grant

Latest NanoPharmaceuticals News

Europe Nanotechnology Markets, 2022-2027: Europe Wide Nanopharmaceuticals Infrastructure, Stronger Materials/Higher Strength Composites, Large Scale 3D Printing with Nanoscale Control, Nanolithography

Oct 3, 2022

Dublin, IRELAND Dublin, Oct. 03, 2022 (GLOBE NEWSWIRE) -- The "Europe Nanotechnology Market Outlook 2027" report has been added to ResearchAndMarkets.com's offering. Europe nanotechnology market is expected to grow at a CAGR of around 14% during the forecasted period of 2022-2027. Nanotechnology is a rapidly growing technology with potential applications in many sectors of the European economy, namely healthcare, electronics, energy, transportation, among others. The technology is revolutionizing majorly every industry, while tremendously attracting worldwide attention. Thus, there lies a great opportunity for industry participants to tap the fast-growing market, which would garner huge revenue on the back of commercialization of the technology. Till 2021, the Europe nanotechnology market has shown impressive growth owing to factors, like increase in government and private sector funding for R&D, partnerships & strategic alliances between countries, and increase in demand for smaller and more powerful devices at affordable prices. At present, the healthcare industry is one of the largest sectors in Europe where nanotechnology has made major breakthrough with its application for the diagnosis and treatment of chronic diseases like cancer, heart ailments, diabetes, etc. Further, significant developments are also being done in other sectors like electronics, environment, and energy. In this report, the analysts have studied the nanotechnology market on segment basis (by type, by application and by region), so as to provide an insight on the current market scenario as well as forecasts of the aforementioned segments till 2027. The report provides an in-depth analysis of all the major segments, taking into account the major developments taking place in the European Countries in the respective segments that will further boost the growth of the Europe nanotechnology market. Further, the application section covers the use of nanotechnology in electronics, energy, healthcare, environment and transportation sectors; while the component section covers the segregation of nanotechnology market into nanomaterials, nanotools, and nanodevices. Additionally, the report covers the country-level analysis of 5 major countries including Germany, France, Switzerland, UK, and Spain in terms of R&D, nanotechnology patent analysis, funding and regulations, to provide an in-depth understanding about the investments and recent research & developments done in the field of nanotechnology. Besides, the report covers the profiles of key players like ASML, STMicroelectronics, Bruker Nano Analytics, etc. with business summary, and recent activities, providing a comprehensive outlook of the Europe nanotechnology industry. Overall, the report provides all the pre-requisite information for clients looking to venture in the industry, and facilitate them to formulate schemes while going for an investment/partnership in the industry. Key Topics Covered:

NanoPharmaceuticals Frequently Asked Questions (FAQ)

  • Where is NanoPharmaceuticals's headquarters?

    NanoPharmaceuticals's headquarters is located at 1 Discovery Drive, Rensselaer.

  • What is NanoPharmaceuticals's latest funding round?

    NanoPharmaceuticals's latest funding round is Unattributed - III.

  • How much did NanoPharmaceuticals raise?

    NanoPharmaceuticals raised a total of $5.95M.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.